Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Gynecol Oncol. 2010 Mar 7;117(2):239–247. doi: 10.1016/j.ygyno.2010.02.006

Fig. 5.

Fig. 5

Methylation of RXFP3 CpG island and clinicopathologic covariates analyses in primary endometrial carcinomas. (A) Methylation profiles of 21 normal endometrial tissues and 109 primary tumors created following MassARRAY analysis. (B) Dot plots pointing that RXFP3 hypermethylation was found in primary endometrial tumors. (C) Dot plots indicating the level of RXFP3 promoter methylation was positively correlated with MSI status. (D) Kaplan-Meier curves disease-free and overall survivals. (A–D) Assays were described as in Fig. 3.